Page 13 - Google Deepmind News Today

Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.

The melding of artificial intelligence and robotics could catapult both to new heights. The melding of artificial intelligence and robotics could catapult both to new heights.

When will AI reach human-level intelligence? AI experts have different answers, but is it the right question? And what would Turing say about todays AI?

Plus: OpenAI is already training its next model.

Mistral AI, a Paris-based startup founded in 2023, is expanding into the U.S. market. The company, led by ex-Google DeepMind and Meta AI researchers, has raised over $500 million and aims to rival OpenAI and Google. Marjorie Janiewicz, Mistral's U.S. general manager, notes growing interest in their AI models, especially from businesses seeking alternatives to big AI stacks.

Musk says he's building anti-woke AI for all our sake. OpenAI also claims to act for humanity. But there's too much at stake to trust them.

Elon Musk and Meta's AI Chief Yann LeCun clash on Twitter over the future of AI research, development, and self-driving technology.

From Audrey Hepburn lookalikes to robots with 360 degree swiveling heads, the development of humanoids is exciting, and maybe slightly terrifying.

The Source for Market Opinions

Some tech workers aren't convinced Sam Altman didn't know OpenAI had non-disparagement clauses in its exit agreements, following Vox reporting.